Collaboration between giant pharmaceutical corporations and patients with very little power just doesn’t work, according to ...

The rise in misconduct allegations is in part the result of a new era of “scientific sleuths” who comb through scientific ...

Australian researchers said that supervised diets with intermittent fasting were for children with serious health conditions, ...

Amid layoffs and a disintegrating share price, former investor darling Ginkgo Bioworks is trying out a new tack to find ...

FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of important documents from a facility ...

GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease, ...

WASHINGTON — Sen. Bill Cassidy (La.), a key Republican senator with seats on the chamber’s health and finance committees, ...

STAT's podcast The Readout LOUD this week discusses cannabinoid receptor drugs in weight loss, what the Fed's rates cut might ...

A Senate committee voted to hold Ralph de la Torre, CEO of troubled Steward Health Care, in contempt. If the full Senate ...

The Federal Reserve yesterday cut interest rates by 50 basis points, in its first time cutting rates in four years. And how ...

A group of lawmakers wants the U.S. Patent & Trademark Office and drug companies to change their approach toward handling ...

A House committee on Wednesday passed a bill to renew a program aimed at aiding development of drugs for rare diseases in ...